Summary
Clinitech Laboratory share holding pattern reports the following shareholding: Clinitech Laboratory Total Promoters is at 64.20%, Mutual Fund at 0.00%, Insurance at 0.00%, Foreign Institutional Investors at 0.32%, Domestic Institutional Investors at 0.00%, and Retail at 35.48%. This breakdown provides a quick snapshot of ownership distribution for Clinitech Laboratory share holding pattern in 2026-27.
Clinitech Laboratory FAQs
As of 06-2026, the promoter shareholding in Clinitech Laboratory stands at 64.2% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Clinitech Laboratory is 0.32% and 0% respectively.
The retail shareholding of the Clinitech Laboratory is 35.48%.
Changes in shareholding patterns of Clinitech Laboratory can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Clinitech Laboratory are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Clinitech Laboratory Associated Pages
